Iomeron (Iomeprol)

Iomeprol consists of iodine atoms that strongly absorb X‑ray photons. When injected, it increases the radiodensity of blood vessels and tissues, creating a clear contrast between structures on X‑ray‑based imaging modalities, thereby improving diagnostic accuracy.

The specific dose of Iomeron is determined by the prescribing physician based on the imaging study, patient weight, renal function, and the route of administration. Dosage calculations are individualized and should follow the relevant clinical guidelines.

Safety data for Iomeron in pregnancy and lactation are limited. It should only be used when clearly needed and after careful risk‑benefit assessment by the healthcare provider. Breastfeeding mothers should discuss potential exposure with their clinician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Iomeron (iomeprol) is a non‑ionic, low‑osmolality contrast medium, offering a favorable safety profile compared with older high‑osmolality agents. Its viscosity and iodine concentration provide high image quality while reducing the incidence of discomfort and adverse reactions relative to some alternative agents.

Iomeron should be stored at controlled room temperature, preferably below 25 °C, in its original sealed container. Protect the solution from direct sunlight, moisture and extreme temperature fluctuations. Do not freeze or shake the vial before use.

Iomeron is supplied as a sterile solution for injection and is administered intravenously, intra‑arterially, or intrathecally by a qualified healthcare professional. The injection rate and volume are adjusted according to the specific imaging protocol and patient characteristics.

The most serious risks include severe allergic reactions such as anaphylaxis, contrast‑induced nephropathy leading to acute kidney injury, and rare events like seizures or cardiovascular collapse. Prompt recognition and emergency management are essential if these reactions occur.

Iomeron is contraindicated in patients with known hypersensitivity to iomeprol or other iodinated contrast agents, those with uncontrolled hyperthyroidism, and individuals with severe renal impairment where alternative imaging strategies are preferred. Clinical judgment should guide use in other high‑risk populations.